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Abstract
Background: Cryotherapy is often used to treat cervical precancer in developing countries.
There are different methods and cryogen gases used for cryotherapy, including the freeze-flush-
freeze (cough) technique employed to minimize gas blockage. However, there is limited
information to compare their effectiveness.
Methods: Using a tissue model, we compared temperature-time curves for four cryotherapy
methods: uninterrupted freezing with nitrous oxide (N2O) and carbon dioxide (CO2), and two
methods using a standard and extended version of the cough technique with CO2.
Results: Uninterrupted freezing with both N2O and CO2 produced tissue temperatures less than
-20°C (-40°C and -30°C respectively). CO2  cryotherapy procedures using the two cough
techniques produced temperatures greater than -20°C in the model tissue.
Conclusion:  CO2 cryotherapy using the cough technique may not achieve sufficiently low
temperatures to produce the desired therapeutic effect. Other alternatives to the prevention of
gas blockage should be developed.
Background
Cryotherapy is a method for the treatment of cervical pre-
cancerous lesions [1,2] that is considered the most suita-
ble option to use in low-resource settings with
underserved populations because it is low cost, requires
no anaesthesia or electricity, and has a low complication
rate [3]. Although nitrous oxide (N2O)-based cryotherapy
is effective [4,5], its limited availability and higher cost in
developing countries make carbon dioxide (CO2)-based
cryotherapy a more practical choice. The reported limita-
tions to using CO2 include blockage of the cryogun during
the cryotherapy procedure, inherently warmer tip temper-
atures due to the physical properties of the gas, and indi-
cations of lower therapeutic effect due to insufficient
depth of tissue destruction during studies that employed
a freeze-flush-freeze cycle ("cough technique") [6].
The "cough technique" has been recommended to avoid
cryogun blockage during treatment [3]. It involves a cyclic
momentary thawing of the cryogun probe by systemati-
cally interrupting freezing. Although the cough technique
is currently being used in developing-country low-
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resource settings, there are no published data on the valid-
ity of this approach or the impact of using the cough tech-
nique on the depth of tissue necrosis generated by these
methods. We developed a system to compare the temper-
ature profile at the probe and in a tissue model of three
different CO2-based methods (an uninterrupted freeze
cycle, the standard cough technique, and an extended
cough technique) as well as the well-characterized N2O
uninterrupted freeze.
Methods
We measured temperatures for a three-minute procedure
using the Wallach LL100 cryogun with a T-2500 2.5 cm
diameter flat probe (Wallach Surgical Devices – Orange,
Connecticut) with thermocouple microprobes IT-23
(Physitemp – Clifton, New Jersey) at the probe/tissue
interface and within the tissue sample at a depth of 5 mm.
The tissue model used was sliced turkey deli meat (30 mm
long × 30 mm wide × 15 mm deep) at room temperature.
The probe was applied to the tissue at an approximate
pressure of 0.7 kg (6.9 N) by fixing the probe vertically
perpendicular to the tissue surface and using the weight of
the cryogun to standardize the force. A photograph of the
model system is shown in Figure 1.
We evaluated three CO2-based cryotherapy techniques:
uninterrupted freezing, the standard cough technique,
and an extended cough technique. For the standard cough
technique, the operator depressed the defrost key every 15
to 20 seconds for approximately one second, released it,
and immediately reengaged the freeze key. To employ the
extended cough technique, the operator inserted a short
pause (approximately onesecond) after releasing the
defrost key and before reengaging the freeze key. During
this pause, the operator waited to hear the cryogun pulse
valve open before reengaging the freeze key.
Individual measurements for each method were repro-
duced five times. Uninterrupted freezing using N2O cryo-
therapy was our referent standard.
The five runs for each group were averaged for a mean
curve. The Kruskal-Wallis test (for nonparametric data)
was used to test for statistical differences (P < 0.05)
between median temperatures for the mean curve for each
cryotherapy technique.
Results
Figure 2 shows the temperature-time curves (n = 5 for each
method) for N2O cryotherapy with uninterrupted freezing
(A), CO2 cryotherapy with uninterrupted freezing (B),
with the extended cough technique (C), and with the
standard cough technique (D). A summary of the data is
shown in Table 1. In our model system, N2O cryotherapy
with uninterrupted freezing achieved the lowest median
temperature at the probe (P = 0.0001) and at a 5 mm
depth in the "tissue" (P = 0.0001) compared to other
A photograph of the model system used to measure tissue  temperature after applying a cryotip (probe) (A) Figure 1
A photograph of the model system used to measure tissue 
temperature after applying a cryotip (probe) (A). The tem-
perature was measured using thermocouples at the probe 
(B) and at a depth of 5 mm into the model tissue (C), com-
posed of a uniform slice of turkey (D).
A
B
C
D
Table 1: A summary of the temperature-time curves from 10 to 180 seconds
N2OC O 2 CO2 (Extended Cough) CO2 (Standard Cough)
Probe Mean (°C) -69 -56 -34 -21
Median (°C) -77 -61 -37 -24
Minimum (°C) -82 -63 -53 -35
Time to -20°C (sec)* 6 4 7 7
Tissue Mean (°C) -12 -10 1 6
Median (°C) -17 -15 -2 3
Minimum (°C) -40 -30 -14 -4
Time to -20°C (sec)* 92 104 n/a n/a
*Time to -20°C started at 10 seconds.BMC Women's Health 2007, 7:16 http://www.biomedcentral.com/1472-6874/7/16
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methods. Similarly, N2O cryotherapy with uninterrupted
freezing was able to achieve the lower median tempera-
ture at the probe (P = 0.0001) and at a 5 mm depth in the
"tissue" (P = 0.0001) than CO2 cryotherapy with uninter-
rupted freezing. Although the extended cough technique
for CO2 cryotherapy achieved a lower temperature for the
probe (P = 0.0001) and tissue (P = 0.0001) measurements
than the standard cough technique, the extended cough
technique only achieved a minimum tissue temperature
of -14°C (versus -40°C for N2O cryotherapy with uninter-
rupted freezing and -30°C for CO2 cryotherapy with unin-
terrupted freezing).
Conclusion
This laboratory-based evidence indicates that both cough
techniques, used to prevent blockage of the cryogun dur-
ing CO2 cryotherapy, significantly affected the tempera-
ture achieved at a 5 mm depth and did not achieve the
minimum temperature of -20°C required for tissue
destruction and therapeutic effects [7]. When compared to
the temperatures achieved with N2O cryotherapy, the ref-
erent treatment shown to be effective for treatment of cer-
vical precancer, it suggests that neither cough technique is
likely to provide the same therapeutic effect as uninter-
rupted freeze. In addition to the importance of minimum
temperature required for necrosis, there are other factors
such as cooling rate and total time at the minimum tem-
perature [8] that are also affected by the cough technique.
The standard cough technique was limited in the mini-
mum temperature achieved due to the design of the
Wallach cryogun internal pulse valve. The valve must be
closed during the defrost cycle and open during the freeze
cycle. The rapid cycling of the standard cough technique
A comparison of temperature-time curves of the probe and model tissue for N2O cryogen (A), CO2 cryogen (B), CO2 cryogen  using the extended cough technique (C), and CO2 cryogen using the standard cough technique (D) Figure 2
A comparison of temperature-time curves of the probe and model tissue for N2O cryogen (A), CO2 cryogen (B), CO2 cryogen 
using the extended cough technique (C), and CO2 cryogen using the standard cough technique (D).
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does not allow time for the valve to reopen following
defrost. It remains closed causing the cryogun to function
at an intermediate temperature between defrost and
freeze. The extended cough (increased time interval
between the freeze cycles) allows time for the valve to
open, ensuring proper functioning during the subsequent
freeze cycle. However, both methods caused significant
temperature variation at the cryogun probe and limit the
minimum temperature achieved in the tissue.
We acknowledge that this is a model system in which tem-
perature was measured at a specific depth rather than the
tissue necrosis, the true desired outcome. Additionally,
because the study employed model tissue rather than
human tissue, additional human studies will be needed to
confirm our laboratory findings. Thus, we can only make
qualitative assessments between different methods. While
our ability to extrapolate as to what will happen in live tis-
sue is limited, it can be anticipated that these higher than
desirable temperatures will be further exacerbated because
of the warming effect of the blood supply leading to
higher tissue temperatures than observed in our model
system.
This evaluation was limited to use of the Wallach LL100;
minimum probe and tissue temperatures may vary if
other cryoguns are used. In addition, frequency of device
blockage is undetermined when using CO2 with other cry-
otherapy devices, which may not incorporate an "active"
defrost feature and hence the cough technique may or
may not be possible.
Based on these data, technical improvements for CO2 cry-
otherapy are necessary to make it a more useful treatment
modality for cervical precancer in underserved popula-
tions who cannot get surgical excision. This may include
methods to dry or condition CO2 to prevent the blockage
in the cryogun during the procedure[9].
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